Overview Performance Dividends Peer Group Options

(ALGBE) Glob Bioenergi - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0011052257

ALGBE: Isobutene, Bio-Based Chemicals, Gas Fermentation Services

Global Bioenergies SA is a pioneering biotechnology company specializing in the conversion of renewable, plant-based feedstocks into high-value chemicals, particularly isobutene. This versatile compound is a critical component in the production of cosmetics, fragrances, and aviation fuels, addressing growing demand for sustainable alternatives in these industries. The company also provides specialized engineering services for gas fermentation processes, optimizing production efficiency for its clients. Additionally, Global Bioenergies is advancing innovative solutions to utilize gaseous carbon sources, such as CO2, CO, and industrial syngas emissions, converting them into valuable chemical compounds. This approach aligns with global efforts to reduce carbon footprints and create circular economies. Headquartered in Evry, France, since its inception in 2008, the company has established itself as a leader in the bio-based chemical sector, leveraging cutting-edge biotechnological processes to drive sustainability and innovation.

Global Bioenergies SA (Ticker: ALGBE) is listed on the Paris stock exchange (PA) as a common stock. The company operates within the Commodity Chemicals sub-industry, focusing on the development and commercialization of bio-based chemicals. Its research and development efforts are centered on fermentation technologies that convert renewable resources into high-performance chemicals, reducing dependence on fossil fuels and lowering greenhouse gas emissions. The companys proprietary processes are designed to be scalable, ensuring their applicability across various industries, from cosmetics to energy.

Based on the provided technical data, Global Bioenergies SAs stock (ALGBE) is currently trading at 1.25 EUR, below its 20-day simple moving average (SMA 20) of 1.38 and slightly above its 50-day SMA of 1.22. The 200-day SMA stands at 1.36, indicating a recent downward trend in the stock price. The Average True Range (ATR) of 0.10 suggests moderate volatility. Over the next three months, the stock is expected to trade within a range of 1.15 to 1.40, with potential resistance at the 1.38 level (SMA 20) and support near 1.20 (SMA 50). From a fundamental perspective, Global Bioenergies SA has a market capitalization of 22.98M EUR, reflecting its position as a small-cap company in the commodity chemicals sector. The price-to-book (P/B) ratio of 4.90 indicates that investors are placing a premium on the companys assets and future growth potential. The return on equity (RoE) of 405.72% highlights strong profitability relative to equity, though this metric should be interpreted cautiously given the companys small size and high valuations. With no forward P/E ratio available, investors are likely pricing in expectations of future earnings growth driven by the companys innovative bio-based chemical solutions. <3_month_forecast> The stock is expected to remain volatile over the next three months, influenced by broader market sentiment toward small-cap renewable energy and chemical companies. The 20-day moving average will likely serve as a key resistance level, while the 50-day moving average could act as a support. Given the companys high P/B ratio and strong RoE, investor interest may remain elevated, potentially driving short-term price appreciation. However, without significant news or earnings catalysts, the stock may trade sideways within the identified range.

Additional Sources for ALGBE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ALGBE Stock Overview

Market Cap in USD 25m
Sector Utilities
Industry Utilities - Diversified
GiC Sub-Industry Commodity Chemicals
IPO / Inception

ALGBE Stock Ratings

Growth 5y -62.0%
Fundamental 14.5%
Dividend 0.0%
Rel. Strength Industry -28.6
Analysts -
Fair Price Momentum 1.18 EUR
Fair Price DCF -

ALGBE Dividends

No Dividends Paid

ALGBE Growth Ratios

Growth Correlation 3m 79.8%
Growth Correlation 12m -80.2%
Growth Correlation 5y -74.4%
CAGR 5y -11.25%
CAGR/Max DD 5y -0.12
Sharpe Ratio 12m -0.50
Alpha -28.24
Beta -1.21
Volatility 101.07%
Current Volume 12.7k
Average Volume 20d 17.4k
What is the price of ALGBE stocks?
As of March 14, 2025, the stock is trading at EUR 1.28 with a total of 12,686 shares traded.
Over the past week, the price has changed by +0.79%, over one month by -7.91%, over three months by +56.48% and over the past year by -31.62%.
Is Glob Bioenergi a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Glob Bioenergi is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 14.49 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALGBE as of March 2025 is 1.18. This means that ALGBE is currently overvalued and has a potential downside of -7.81%.
Is ALGBE a buy, sell or hold?
Glob Bioenergi has no consensus analysts rating.
What are the forecast for ALGBE stock price target?
According to ValueRays Forecast Model, ALGBE Glob Bioenergi will be worth about 1.3 in March 2026. The stock is currently trading at 1.28. This means that the stock has a potential downside of -0.78%.
Issuer Forecast Upside
Wallstreet Target Price 2.4 87.5%
Analysts Target Price - -
ValueRay Target Price 1.3 -0.8%